Medinotec (MDNC) Cash & Equivalents (2022 - 2026)

Medinotec's Cash & Equivalents history runs 5 years deep, the most recent figure standing at $2.5 million for Q2 2026.

• Quarterly Cash & Equivalents rose 29.09% year-over-year to $2.5 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $2.5 million (up 29.09% YoY) and the FY2026 annual result came in at $2.8 million, changed 0.46% from the prior year.
• Cash & Equivalents was $2.5 million for Q2 2026 at Medinotec, down from $2.8 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $3.6 million in Q2 2022 and bottomed at $131577.0 in Q1 2022.
• A 5-year average of $2.6 million and a median of $2.8 million in 2024 frame the typical range for Cash & Equivalents.
• Peak annual rise in Cash & Equivalents reached 2048.9% in 2023, while the deepest fall reached 23.93% in 2023.
• Medinotec's Cash & Equivalents stood at $2.8 million in 2022, then declined by 5.9% to $2.7 million in 2023, then decreased by 0.08% to $2.7 million in 2024, then increased by 6.74% to $2.9 million in 2025, then dropped by 11.85% to $2.5 million in 2026.
• Business Quant data shows MDNC's Cash & Equivalents at $2.5 million in Q2 2026, $2.8 million in Q1 2026, and $2.9 million in Q4 2025.